CINECA IRIS Institutional Research Information System

LOPIANO, Leonardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.115
EU - Europa 14.684
AS - Asia 12.382
SA - Sud America 1.942
AF - Africa 248
OC - Oceania 228
Continente sconosciuto - Info sul continente non disponibili 11
Totale 50.610
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.468
IT - Italia 4.770
SG - Singapore 4.676
CN - Cina 3.825
BR - Brasile 1.509
DE - Germania 1.486
IE - Irlanda 1.289
SE - Svezia 1.215
FR - Francia 1.175
FI - Finlandia 829
VN - Vietnam 825
GB - Regno Unito 818
KR - Corea 639
JP - Giappone 613
UA - Ucraina 516
CA - Canada 460
AT - Austria 454
IN - India 431
ES - Italia 394
HK - Hong Kong 372
PL - Polonia 341
NL - Olanda 339
AU - Australia 207
RU - Federazione Russa 185
AR - Argentina 175
ID - Indonesia 164
BE - Belgio 155
TR - Turchia 151
MX - Messico 121
PT - Portogallo 111
CH - Svizzera 106
GR - Grecia 102
TW - Taiwan 100
BD - Bangladesh 83
DK - Danimarca 77
ZA - Sudafrica 69
IQ - Iraq 60
EC - Ecuador 58
CO - Colombia 53
RO - Romania 50
CL - Cile 47
UZ - Uzbekistan 46
IL - Israele 45
PK - Pakistan 43
SA - Arabia Saudita 41
CZ - Repubblica Ceca 40
BG - Bulgaria 33
MA - Marocco 33
PE - Perù 33
EG - Egitto 32
IR - Iran 32
TH - Thailandia 31
MY - Malesia 30
NO - Norvegia 30
AE - Emirati Arabi Uniti 28
LT - Lituania 24
SN - Senegal 23
PY - Paraguay 22
NZ - Nuova Zelanda 20
TN - Tunisia 20
UY - Uruguay 20
RS - Serbia 19
PH - Filippine 18
SI - Slovenia 18
VE - Venezuela 18
HR - Croazia 15
SK - Slovacchia (Repubblica Slovacca) 15
BY - Bielorussia 14
NP - Nepal 13
HU - Ungheria 12
JO - Giordania 12
KZ - Kazakistan 12
LB - Libano 12
NG - Nigeria 12
HN - Honduras 11
AZ - Azerbaigian 10
CI - Costa d'Avorio 10
DO - Repubblica Dominicana 10
KE - Kenya 10
AL - Albania 9
CR - Costa Rica 9
DZ - Algeria 9
JM - Giamaica 9
CY - Cipro 8
LU - Lussemburgo 8
OM - Oman 8
BA - Bosnia-Erzegovina 7
GE - Georgia 7
PA - Panama 7
EE - Estonia 6
ET - Etiopia 6
EU - Europa 6
GA - Gabon 6
IS - Islanda 6
KW - Kuwait 6
MD - Moldavia 6
MO - Macao, regione amministrativa speciale della Cina 6
SV - El Salvador 6
BO - Bolivia 5
QA - Qatar 5
Totale 50.530
Salva come PNG Salva come JPEG
Città #
Singapore 2.578
Chandler 1.972
Beijing 1.958
Ashburn 1.391
Santa Clara 1.276
Dublin 1.260
Houston 1.231
Fairfield 802
Torino 663
Dallas 607
Ann Arbor 515
Villeurbanne 483
Wilmington 470
San Jose 454
Nyköping 424
Princeton 420
Redwood City 420
Milan 404
Woodbridge 397
Medford 396
Jacksonville 395
Vienna 386
Columbus 373
Turin 344
Seattle 341
Los Angeles 326
Dearborn 313
Cambridge 297
Warsaw 289
Hong Kong 282
Rome 273
Seoul 262
Munich 259
Helsinki 250
Boston 237
Hefei 221
Buffalo 219
Ho Chi Minh City 206
The Dalles 182
New York 171
Pisa 167
São Paulo 163
Dong Ket 162
Tokyo 158
Boardman 138
Hanoi 129
Ottawa 129
Guangzhou 122
Shanghai 121
Jakarta 108
Madrid 99
London 98
Lauterbourg 97
Nanjing 89
Toronto 88
Hangzhou 83
Frankfurt am Main 82
Brussels 77
Fremont 73
Redondo Beach 73
Düsseldorf 72
Verona 70
Bengaluru 69
Chengdu 69
Taipei 65
Duncan 63
Turku 61
Bologna 60
Norwalk 58
Paris 58
Amsterdam 55
Sydney 52
Florence 51
Nuremberg 51
Chicago 50
Phoenix 50
Wuhan 49
Naples 47
Palermo 46
Washington 44
Rio de Janeiro 43
Stockholm 43
Denver 42
Catania 41
Istanbul 41
Johannesburg 41
San Diego 41
Silver Spring 41
Mumbai 38
Athens 37
Orem 37
Falls Church 36
Brooklyn 35
Lisbon 35
Atlanta 34
Belo Horizonte 34
Berlin 34
Bari 33
Santiago 33
Barcelona 32
Totale 27.894
Salva come PNG Salva come JPEG
Nome #
Early DEtection of wEaring off in Parkinson disease: The DEEP study 1.808
Il Bergamini di Neurologia 1.282
Validation of the Italian version of the Movement Disorder Society - Unified Parkinson's Disease Rating Scale. 902
Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients. 864
Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease? 804
Impulse control behaviors and subthalamic deep brain stimulation in Parkinson disease 729
Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study. 692
Subcutaneous vs intravenous administration of immunoglobulin in chronic inflammatory demyelinating polyneuropathy: an Italian cost-minimization analysis 597
Neuropathy and levodopa in Parkinson's disease: Evidence from a multicenter study 583
Network Analysis Identifies Disease-Specific Pathways for Parkinson’s Disease 564
Progressive gait ataxia following deep brain stimulation for essential tremor: adverse effect or lack of efficacy? 502
Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: a 7-year experience 496
Levodopa-carbidopa intestinal gel infusion and weight loss in Parkinson's disease 475
The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients. 435
Subthalamic deep brain stimulation: clinical and neuropsychological outcomes in mild cognitive impaired parkinsonian patients. 403
Transient effects of 80 Hz stimulation on gait in STN DBS treated PD patients: a 15 months follow-up study. 395
Increased risk of impulse control symptoms in Parkinson's disease with REM sleep behaviour disorder 384
NADPH oxidase 2 (NOX2) enzyme activation in patients with chronic inflammatory demyelinating polyneuropathy 379
Characterization of the thalamic-subthalamic circuit involved in the placebo response through single-neuron recording in Parkinson patients 375
80 Hz versus 130 Hz subthalamic nucleus deep brain stimulation: effects on involuntary movements. 351
Transdermal apomorphine permeation from microemulsions: a new treatment in Parkinson's disease 345
Three novel missense mutations in SLC20A2 associated with idiopathic basal ganglia calcification 343
Medical therapy and subthalamic deep brain stimulation in advanced Parkinson's disease: a different long-term outcome? 342
Subthalamic nucleus deep brain stimulation outcome in young onset Parkinson's disease: a role for age at disease onset? 313
Gut microbiota and metabolome distinctive features in parkinson disease: Focus on levodopa and levodopa carbidopa intrajejunal gel 310
Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. 307
Self-unawareness of levodopa induced dyskinesias in patients with Parkinson's disease. 307
Prospective assessment of peripheral neuropathy in Duodopa-treated parkinsonian patients 296
Deep Brain Stimulation of the subthalamic nucleus does not negatively affect social cognitive abilities of patients with Parkinson's disease 294
Does intraoperative microrecording really increase the risk of hemorrhagic complications in deep brain stimulation? 265
Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study 261
Emotion Processing in Parkinson’s Disease: A Three-Level Study on Recognition, Representation, and Regulation 245
Alessitimia e depressione in pazienti con malattia di Parkinson sottoposti a deep brain stimulation del subtalamo: uno studio caso-controllo. 240
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 240
Teaching neurons to respond to placebos 233
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. 220
When words are painful: unraveling the mechanisms of the nocebo effect 218
A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non-demented Parkinson's disease patients 218
Stimulation of the subthalamic area modulating movement and behavior 213
Alexithymia in patients with Parkinson's disease treated with DBS of the subthalamic nucleus: a case-control study 209
Reverse blood pressure dipping as marker of dysautonomia in Parkinson disease 206
Cleptomania associata a terapia con dopaminoagonista in un paziente affetto da malattia di Parkinson 203
Analisi dei costi della stimolazione cerebrale profonda (DBS) nella malattia di Parkinson: uno studio osservazionale su pazienti italiani. 191
Nocturnal anomalous movement reduction and sleep microstructure analysis in parkinsonian patients during 1-night transdermal apomorphine treatment. 191
Beyond 35 years of Parkinson’s disease: a comprehensive clinical and instrumental assessment 191
Evidence for a glycidic-lipidic matrix in human neuromelanin, potentially responsible for the enhanced iron sequestering ability of substantia nigra. 187
Impulsivities and Parkinson's disease: Delay aversion is not worsened by Deep Brain Stimulation of the Subthalamic Nucleus 181
Neurological comorbidity and severity of COVID-19 177
Motor and non-motor outcomes in patients with advanced Parkinson’s disease treated with levodopa/carbidopa intestinal gel: final results of the GREENFIELD observational study 175
Narrative abilities in Parkinson's disease:A pilot study on italian-speaking patients treated with deep brain stimulation of the subthalamic nucleus 173
What Happens When I Watch a Ballet and I Am Dyskinetic? A fMRI Case Report in Parkinson Disease. 173
Alpha-Synuclein protects SH-SY5Y cells from dopamine toxicity 168
Analysis of CHCHD2 and CHCHD10 genes in patients with Parkinson’s disease and mitochondrial myopathy. 168
Caregiver burden and its related factors in advanced Parkinson’s disease: data from the PREDICT study 165
Safety and efficacy of tolcapone in Parkinson’s disease: systematic review 164
Nuclear magnetic resonance spectroscopy characterization and iron content determination of human mesencephalic neuromelanin. 163
Open versus hidden medical treatments: the patient's knowledge about a therapy affects the therapy outcome. 161
Effectiveness of a dance-physiotherapy combined intervention in Parkinson's disease: a randomized controlled pilot trial 156
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 151
Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age 150
Apathy and verbal fluency in STN-stimulated PD patients: An observational follow-up study 147
An original study of mastication in patients with advanced Parkinson disease with and without therapy and deep brain stimulation 146
Antiparkinsonian therapy modifications in PD patients after STN DBS: A retrospective observational analysis 145
The PRIAMO study: age- and sex-related relationship between prodromal constipation and disease phenotype in early Parkinson’s disease 144
Botulinum toxin for Pisa syndrome: An MRI-, ultrasound- and electromyography-guided pilot study 143
Restricted dissociated sensory loss in a patient with a lateral medullary syndrome: A clinical-MRI study. 142
Apatia in pazienti con malattia di Parkinson sottoposti a DBS del nucleo subtalamico. 142
Neuropsychological changes 1-year after subthalamic DBS in PD patients: a prospective controlled study 141
Adaptive deep brain stimulation controls levodopa-induced side effects in Parkinsonian patients 141
Anxiety, depression, and worries in advanced Parkinson disease during COVID-19 pandemic 141
Stretch reflex of quadriceps femoris and its relation to rigidity in Parkinson's disease. 140
Deep brain stimulation of subthalamic nucleus: behavioral modifications and familiar relations 140
AN ORIGINAL STUDY OF MASTICATION IN PATIENTS WITH ADVANCED PARKINSON DISEASE WITH AND WITHOUT ME- DICAL THERAPY AND DEEP BRAIN STIMULATION 140
Electrophysiological properties of thalamic, subthalamic and nigral neurons during the anti-parkinsonian placebo response 139
Personality and Deep Brain Stimulation of the subthalamic nucleus in Parkinson's disease 139
Deep brain stimulation in Parkinson's disease: comparison of pre- and post-operative neuropsychological evaluation 138
NADPH Oxidases (NOX) Enzymes Induced Oxidative Stress in CIDP Patients 138
Consensus on the treatment of dysphagia in Parkinson's disease 138
An original study of mastication in patients with advanced Parkinson disease with and without therapy and deep brain stimulation. 136
Cardiovascular autonomic neuropathy and falls in Parkinson disease: a prospective cohort study 136
The placebo effect on bradykinesia in Parkinson's disease with and without prior drug conditioning 135
A polysomnographic study in parkinsonian patients treated with intestinal levodopa infusion 135
Sleep microstructure in Parkinson's disease: cycling alternating pattern (CAP) as a sensitive marker of early NREM sleep instability 135
The dominant-subthalamic nucleus phenomenon in bilateral deep brain stimulation for Parkinson's disease: Evidence from a gait analysis study 135
3 years comparison between duodopa and Deep Brain Stimulation 134
Pure autonomic failure versus prodromal dysautonomia in Parkinson’s disease: Insights from the bedside 134
Proteome analysis of mesencephalic tissues: evidence for Parkinson's disease. 133
Anhedonia and cognitive impairment in Parkinson's disease: Italian validation of the Snaith-Hamilton Pleasure Scale and its application in the clinical routine practice during the PRIAMO study. 132
Apathy and verbal fluency in STN-stimulated PD patients 131
Benign versus malignant Parkinson disease: the unexpected silver lining of motor complications 131
Advanced therapies in Parkinson's disease: Long-term retrospective study 130
Increased prevalence of impulse control disorder symptoms in endocrine diseases treated with dopamine agonists: a cross-sectional study 130
NADPH oxidases (NOX) enzymes induced oxidative stress in CIDP patients 129
Novel parkin mutations detected in patients with early-onset Parkinson's disease 129
Role of the cingulate cortex in dyskinesias-reduced-self-awareness: An fMRI study on Parkinson's disease patients 129
Deep brain stimulation of the subthalamic nucleus in PD: an analysis of the exclusion causes 128
Role of NOX2 enzyme activity in neuroinflammation: preliminary results in Amyotrophic Lateral Sclerosis and Parkinson’s disease 128
Characterizing advanced Parkinson's disease: OBSERVE-PD observational study results of 2615 patients 127
[Role of the cerebellar vermis in the long term habituation of the acoustic startle response in the rat] 126
Beyond Nine Years of Continuous Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease 125
Totale 27.365
Salva come PNG Salva come JPEG
Categoria #
all - tutte 150.477
article - articoli 0
book - libri 0
conference - conferenze 19.037
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 169.514
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.208 0 0 0 0 0 0 279 259 470 380 296 524
2021/20224.459 231 180 208 431 234 229 271 225 202 344 961 943
2022/20236.254 688 527 200 609 600 1.519 459 374 596 190 322 170
2023/20243.093 328 525 151 214 260 332 122 211 45 225 254 426
2024/20258.890 199 487 305 789 1.950 726 437 602 891 602 699 1.203
2025/202610.056 1.729 839 1.450 2.085 1.930 950 1.073 0 0 0 0 0
Totale 51.781